Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
35M
-
Shares change
-
+3.52M
-
Total reported value, excl. options
-
$1.5B
-
Value change
-
+$151M
-
Put/Call ratio
-
0.24
-
Number of buys
-
69
-
Number of sells
-
-27
-
Price
-
$42.80
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share (SLNO) as of Q1 2024
118 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2024.
SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share (SLNO) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35M shares
of 50M outstanding shares and own 69.97% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (8.42M shares), Carlyle Group Inc. (4.07M shares), PERCEPTIVE ADVISORS LLC (3.07M shares), JANUS HENDERSON GROUP PLC (2.87M shares), Nantahala Capital Management, LLC (2.41M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.94M shares), Avoro Capital Advisors LLC (1.63M shares), Vestal Point Capital, LP (1.25M shares), STATE STREET CORP (971K shares), and VANGUARD GROUP INC (970K shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.